Oliver Sartor, MD, is the C.E. and Bernadine Laborde professor of cancer research, medical director of the Tulane Cancer Center, and assistant dean for oncology at Tulane University School of Medicine in New Orleans, Louisiana. His clinical and research interests have focused broadly on prostate cancer over the years. Dr Sartor’s more than 400 scientific publications range from genetic studies on prostate cancer to studies of ethnic populations. He has given hundreds of lectures and presentations on advanced prostate cancer at meetings in 33 countries. Dr Sartor was past chief editor of Clinical Genitourinary Cancer and a reviewer for numerous peer-reviewed publications. He is medical oncology chair of the Genitourinary Cancer Committee of the NRG, a national clinical trials cooperative.

Neal D. Shore, MD, FACS, is the medical director for the Carolina Urologic Research Center and practices with Atlantic Urology Clinics in Myrtle Beach, South Carolina. Dr Shore has conducted more than 350 clinical trials that focus mainly on GU oncology, has served on the executive boards of the Society of Urologic Oncology, Bladder Cancer Advocacy Network and the Society of Urologic Oncology Clinical Trials Consortium, and is immediate past president of the Large Urology Group Practice Association. He is a founder for the CUSP Clinical Trials Consortium and DASHKO, large urology practices data registries. He has over 150 peer-reviewed publications, several book chapters, and is a peer reviewer for numerous high-impact medical journals. He earned his MD from Duke University Medical School and general surgery/urology residency at New York Hospital-Cornell and Memorial Sloan Kettering Cancer Center.